PRKDC and non-small cell lung carcinoma: The above results indicate that in non-small cell lung cancers, rs2273953 (TP73), rs12334811(DNPK1), rs2279744 (MDM2) and rs2909430 (TP53) can be used as biological markers for clinical treatment and prognosis.